MedImmune FluMist Flyer Discontinued Following FDA Warning Letter
MedImmune has discontinued distribution of a consumer-directed flyer for the intranasal flu vaccine FluMist after FDA said the promotion failed to provide adequate risk information and directions for use
You may also be interested in...
Direct-to-consumer advertising does not endanger the public health because access to prescription drugs is controlled by physicians, not the public, the Washington Legal Foundation's new advertising regulation watchdog group suggests
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials